SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-23-000326
Filing Date
2023-03-09
Accepted
2023-03-09 16:16:00
Documents
58
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e4477_10q.htm   iXBRL 10-Q 910893
2 EXHIBIT 31.1 e4477_ex31-1.htm EX-31.1 7953
3 EXHIBIT 31.2 e4477_ex31-2.htm EX-31.2 8212
4 EXHIBIT 32.1 e4477_ex32-1.htm EX-32.1 3983
5 EXHIBIT 32.2 e4477_ex32-2.htm EX-32.2 4610
  Complete submission text file 0001731122-23-000326.txt   4656960

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enob-20221231.xsd EX-101.SCH 36753
7 XBRL CALCULATION FILE enob-20221231_cal.xml EX-101.CAL 45636
8 XBRL DEFINITION FILE enob-20221231_def.xml EX-101.DEF 141300
9 XBRL LABEL FILE enob-20221231_lab.xml EX-101.LAB 309866
10 XBRL PRESENTATION FILE enob-20221231_pre.xml EX-101.PRE 253125
52 EXTRACTED XBRL INSTANCE DOCUMENT e4477_10q_htm.xml XML 622209
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38758 | Film No.: 23719939
SIC: 2834 Pharmaceutical Preparations